Sukhtian Ghiath M.
Insider CIK 1717441 · OTLK Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-08-12 | 2026-08-14 | 2,525,252 | — | $0 | 2,525,252 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-08-12 | 2026-08-14 | 2,525,252 | $0.99 | $2.50M | 24,617,320 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-08-12 | 2026-08-14 | 2,525,252 | — | $0 | 2,525,252 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-08-12 | 2026-08-14 | 2,525,252 | $0.99 | $2.50M | 24,617,320 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-05-28 | 2026-06-01 | 8,571,428 | — | $0 | 8,571,428 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-05-28 | 2026-06-01 | 3,458,571 | — | $0 | 3,458,571 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | H Expire deriv | 2026-05-28 | 2026-06-01 | 3,458,571 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | H Expire deriv | 2026-05-28 | 2026-06-01 | 8,571,428 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | H Expire deriv | 2026-05-28 | 2026-06-01 | 3,458,571 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy deriv | 2026-05-28 | 2026-06-01 | 3,458,571 | — | $0 | 3,458,571 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2026-05-28 | 2026-06-01 | 8,539,709 | $0.59 | $5.04M | 22,092,068 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-05-27 | 2025-05-28 | 8,571,428 | — | $0 | 8,571,428 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2025-05-27 | 2025-05-28 | 4,285,714 | $1.40 | $6.00M | 13,552,359 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-01-17 | 2025-01-22 | 3,458,571 | — | $0 | 3,458,571 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2025-01-17 | 2025-01-22 | 3,458,571 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-01-17 | 2025-01-22 | 3,458,571 | — | $0 | 3,458,571 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2025-01-17 | 2025-01-22 | 3,458,571 | — | $0 | 3,458,571 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2025-01-17 | 2025-01-22 | 3,458,571 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2025-01-17 | 2025-03-12 | 3,458,571 | $2.51 | $8.68M | 9,266,645 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2024-03-18 | 2024-03-20 | 3,458,571 | — | $0 | 3,458,571 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2024-03-18 | 2024-03-20 | 2,305,714 | — | $0 | 5,808,074 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2022-12-28 | 2022-12-29 | 14,230,418 | $0.88 | $12.52M | 70,047,204 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other | 2022-04-21 | 2022-07-07 | 27,982,529 | — | $0 | 55,816,786 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other | 2022-02-01 | 2022-02-01 | 2,500,000 | $1.25 | $3.13M | 27,982,529 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-11-29 | 2021-12-01 | 16,000,000 | $1.25 | $20.00M | 27,834,257 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2021-02-10 | 2021-02-11 | 1,013,627 | $1.00 | $1.01M | 11,834,257 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | P Buy | 2021-02-02 | 2021-02-02 | 8,360,000 | $1.00 | $8.36M | 10,820,630 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-03-23 | 2020-03-23 | 68,112 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2020-03-23 | 2020-03-23 | 29,358,621 | — | $0 | 50,965,058 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-03-19 | 2020-03-23 | 68,112 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-23 | 68,112 | — | $0 | 68,112 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-02-26 | 2020-02-27 | 1,230,315 | $0.13 | $159.9K | 1,230,315 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2020-02-26 | 2020-02-27 | 2,460,630 | $1.02 | $2.51M | 2,460,630 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-01-29 | 2020-01-29 | 2,093,750 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-01-29 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2020-01-29 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2020-01-29 | 2020-01-29 | 4,657,852 | $0.23 | $1.07M | 21,606,437 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 1,282,051 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 1,282,051 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-01-27 | 2020-01-29 | 1,282,051 | $1.00 | $1.28M | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2020-01-27 | 2020-01-29 | 2,093,750 | — | $0 | 2,039,750 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | D To issuer deriv | 2020-01-27 | 2020-01-29 | 2,093,750 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-12-31 | 2019-12-31 | 1,661 | — | $0 | 68,112 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2019-12-23 | 2019-12-30 | 3,636,364 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2019-12-23 | 2019-12-30 | 2,909,091 | $0.23 | $669.1K | 16,948,585 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-09-30 | 2019-09-30 | 1,620 | — | $0 | 66,451 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-06-30 | 2019-07-01 | 1,581 | — | $0 | 64,831 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise deriv | 2019-06-17 | 2019-06-19 | 3,636,364 | — | $0 | 0 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | M Exercise | 2019-06-17 | 2019-06-19 | 2,181,818 | — | $0 | 14,039,494 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-04-12 | 2019-04-16 | 3,636,364 | — | $0 | 3,636,364 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award deriv | 2019-04-12 | 2019-04-16 | 3,636,364 | — | $0 | 3,636,364 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | A Award | 2019-04-12 | 2019-04-16 | 3,636,364 | $2.75 | $10.00M | 11,857,676 | SEC↗ |
| OTLK Outlook Therapeutics, Inc. | J Other deriv | 2019-03-31 | 2019-04-02 | 1,542 | — | $0 | 63,250 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-07-18 | 2018-07-20 | 58,735 | — | $0 | 58,735 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-07-18 | 2018-07-20 | 6,526 | — | $0 | 58,735 | SEC↗ |
| ONS Oncobiologics, Inc. | D To issuer deriv | 2018-07-18 | 2018-07-20 | 58,735 | — | $0 | 0 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion deriv | 2018-06-20 | 2018-06-25 | 208,836 | — | $0 | 52,209 | SEC↗ |
| ONS Oncobiologics, Inc. | C Conversion | 2018-06-20 | 2018-06-25 | 31,572,617 | — | $0 | 44,327,383 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-06-08 | 2018-06-25 | 10,256,410 | $0.13 | $1.33M | 20,512,820 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2018-06-08 | 2018-06-25 | 6,377,383 | $0.98 | $6.25M | 12,754,766 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award deriv | 2018-05-14 | 2018-06-25 | 10,256,410 | $0.13 | $1.33M | 10,256,410 | SEC↗ |
| ONS Oncobiologics, Inc. | A Award | 2018-05-14 | 2018-06-25 | 6,377,383 | $0.98 | $6.25M | 6,377,383 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2018-03-31 | 2018-06-25 | 6,367 | — | $0 | 261,045 | SEC↗ |
| ONS Oncobiologics, Inc. | J Other deriv | 2017-12-31 | 2018-06-25 | 4,678 | — | $0 | 254,678 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2017-10-31 | 2017-11-01 | 217,372 | $100.00 | $21.74M | 250,000 | SEC↗ |
| ONS Oncobiologics, Inc. | P Buy deriv | 2017-10-31 | 2017-11-01 | 16,750,000 | — | $0 | 16,750,000 | SEC↗ |